7-substituted 1-aryl-naphthyridine-3-carboxylic acid amides and use thereof
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Oct 18, 2022
Grant Date -
Aug 26, 2021
app pub date -
Jan 28, 2021
filing date -
Sep 14, 2016
priority date (Note) -
In Force
status (Latency Note)
Importance
Loading Importance Indicators... 
Abstract
The present application relates to novel 7-substituted 1-arylnaphthyridine-3-carboxamides, to processes for their preparation, to their use, alone or in combinations, for the treatment and/or prevention of diseases, and to their use for the production of medicaments for the treatment and/or prevention of diseases, in particular for the treatment and/or prevention of cardiovascular disorders and/or renal disorders.
First Claim
Other Claims data not available
Family
Loading Family data...
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
- 0 Citation Count
- A61K Class
- 0 % this patent is cited more than
- 3 Age
Maintenance Fees
| Fee | Large entity fee | small entity fee | micro entity fee | due date |
|---|---|---|---|---|
| 3.5 Year Payment | $1600.00 | $800.00 | $400.00 | Apr 18, 2026 |
| 7.5 Year Payment | $3600.00 | $1800.00 | $900.00 | Apr 18, 2030 |
| 11.5 Year Payment | $7400.00 | $3700.00 | $1850.00 | Apr 18, 2034 |
